A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants
Clinical trial NCT01866007 · COMPLETED
Trial details
- NCT number
- NCT01866007
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-09
- Primary completion
- 2013-09-20
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.